What are the Current Therapeutic Strategies Targeting Aβ?
Current therapeutic strategies aim to reduce the production or enhance the clearance of Aβ peptides. These include β-secretase and γ-secretase inhibitors, which prevent the formation of Aβ peptides. Immunotherapy approaches involve the use of antibodies to promote the clearance of Aβ plaques from the brain.
